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Abstract
Evolution of resistance to drugs and pesticides poses a serious threat to human health and agricultural production. CYP51
encodes the target site of azole fungicides, widely used clinically and in agriculture. Azole resistance can evolve due to
point mutations or overexpression of CYP51, and previous studies have shown that fungicide-resistant alleles have arisen
by de novo mutation. Paralogs CYP51A and CYP51B are found in filamentous ascomycetes, but CYP51A has been lost
from multiple lineages. Here, we show that in the barley pathogen Rhynchosporium commune, re-emergence of CYP51A
constitutes a novel mechanism for the evolution of resistance to azoles. Pyrosequencing analysis of historical barley leaf
samples from a unique long-term experiment from 1892 to 2008 indicates that the majority of the R. commune pop-
ulation lacked CYP51A until 1985, after which the frequency of CYP51A rapidly increased. Functional analysis demon-
strates that CYP51A retains the same substrate as CYP51B, but with different transcriptional regulation. Phylogenetic
analyses show that the origin of CYP51A far predates azole use, and newly sequenced Rhynchosporium genomes show
CYP51A persisting in the R. commune lineage rather than being regained by horizontal gene transfer; therefore, CYP51A
re-emergence provides an example of adaptation to novel compounds by selection from standing genetic variation.
Key words: standing variation, gene duplication, resistance, fungicides, triazoles, Rhynchosporium.
Introduction
Resistance to drugs and pesticides is a major challenge in
medicine (McKenna 2013) and agriculture (Heckel 2012).
Understanding the evolutionary mechanisms involved in
the emergence and spread of resistance can aid resistance
risk assessment and management (MacLean et al. 2010).
One relevant evolutionary question is the extent to which
populations adapt to novel environments, such as a new
biocide, through de novo mutations or through selection
from standing genetic variation, as this will affect the proba-
bility and speed of emergence of resistant alleles (Hermisson
and Pennings 2005). Previous studies have indicated de novo
origins for fungicide resistance mutations (Torriani et al. 2009;
Camps et al. 2012). Selection from standing variation can be
inferred from the population genetic signature of selection, or
by tracing the history of the selected allele (Barrett and
Schluter 2008). In this study, we have taken the second
approach, following the evolutionary history of CYP51A in
Rhynchosporium commune through comparative genomics
and analysis of historical infected plant samples.
Duplicate genes have long been considered an important
source of genetic adaptive potential (Ohno 1970; Zhang 2003;
Dittmar and Liberles 2010). Extensive research has considered
the origin and fate of duplicated genes, but focusing on
the likelihood of emergence of copy number variants
(Lynch and Conery 2000); loss or change of function
through pseudogenization, neofunctionalization, or
subfunctionalization (Conant and Wolfe 2008; Innan and
Kondrashov 2010); and mechanisms of functional divergence
before or after duplication (Hughes 1994; Na¨svall et al. 2012);
around the time of duplication under given conditions of
selection and drift, rather than future changes if selective
pressures alter. In this study, the use of historical samples
enables changes in duplicate gene frequency over time
to be measured directly, revealing responses to changes in
selection.
The azoles are widely used as both clinical and agricultural
fungicides (Kelly et al. 1993). Clinically, the importance of
antifungal therapies has increased as HIV, transplant antire-
jection drugs, and some cancer treatments leave patients
immunocompromised and vulnerable to fungal infections
(Denning and Hope 2010). In agriculture, crop diseases
result in yield losses of 10–15% of global food production
(Oerke and Dehne 2004; Strange and Scott 2005), a continual
obstacle to feeding a growing population. In 2005, azoles rep-
resented 25.3% of the $8.9 billion global agricultural fungicide
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market (Morton and Staub 2008). The target site of the azoles
is fungal CYP51. CYP51 is a cytochrome P450, sterol
14a-demethylase, involved in the biosynthesis of ergosterol
in fungi, cholesterol in mammals, and sitosterol in plants
(Lepesheva and Waterman 2007).
Recently, some ascomycete fungi have been found to pos-
sess multiple CYP51 paralogs, with two paralogs, CYP51A and
CYP51B, in Aspergillus fumigatus (Mellado et al. 2001),
A. nidulans (Da Silva Ferreira et al. 2005), and Magnaporthe
oryzae (Yan et al. 2011), and three in A. oryzae (Da Silva
Ferreira et al. 2005) and Fusarium spp. (Deng et al. 2007).
The reasons why some species possess multiple CYP51 para-
logs, and others only one, are not yet known. Knocking out
the CYP51A paralog from wild-type isolates of A. fumigatus
(Mellado et al. 2005) and Fusarium graminearum (Fan et al.
2013) resulted in increased azole sensitivity, suggesting that
the presence of additional CYP51 paralogs can confer reduced
intrinsic azole sensitivity.
Acquired reductions in sensitivity to azoles may result
from mutations or overexpression of CYP51. Various point
mutations, with quantitative, interacting effects on azole sen-
sitivity, have been reported in the single CYP51 paralogs of the
clinical pathogen Candida albicans (Morio et al. 2010) and
the wheat pathogen Mycosphaerella graminicola (Cools et al.
2010). Reduced azole sensitivity due to constitutive overex-
pression of CYP51 was first reported in citrus green mould,
Penicillium digitatum (Hamamoto et al. 2000). A combination
of promoter changes resulting in overexpression and point
mutations in the coding sequence has been reported in the
CYP51A paralog in clinical isolates of A. fumigatus (Mellado
et al. 2007). Nontarget-site mechanisms, such as enhanced
efflux (de Waard and van Nistelrooy 1980) or altered sterol
metabolism (Kelly et al. 1995), may also reduce azole sensi-
tivity. Reduced sensitivity to azoles has now been reported in
the field or in field isolates of over 20 plant pathogens
(Fungicide Resistance Action Committee 2013, www.frac.
info, last accessed April 16, 2014).
Rhynchosporium commune Zaffarano, McDonald, and
Linde is an ascomycete fungal pathogen causing barley leaf
blotch or scald. Previously known as R. secalis (Oud.) Davis
(Caldwell 1937), it has recently been shown that R. secalis s.l.
comprises three distinct host-specialized lineages, with
R. secalis s.s. now referring only to the rye-infecting species,
R. agropyri infecting Agropyron spp. and R. commune infect-
ing barley (Zaffarano et al. 2011). Rhynchosporium commune
causes necrotic lesions on infected leaves, resulting in grain
yield reductions of up to 30% if untreated (Mayfield and Clare
1991). Although some barley varieties provide partial resis-
tance, control is still heavily reliant on fungicides. In 2010,
winter barley crops in the United Kingdom received an aver-
age of 2.1 fungicide applications, with 98.5% of crop area
treated, and 54% of treatments containing an azole
(Garthwaite et al. 2011).
The first azole to be used on barley in the United Kingdom
was introduced in the mid-1970s. By 1985, surveys of azole
sensitivity in R. commune revealed a 5- to 10-fold decrease in
sensitivity to the earlier azoles relative to baseline testing in
1975–1981 (Kendall et al. 1993). Since the introduction of
epoxiconazole in the late 1990s and prothioconazole in the
mid-2000s, further sensitivity shifts have affected these com-
pounds, but they retain some effectiveness in the field (Oxley
et al. 2008). The mechanisms responsible for these azole sen-
sitivity shifts in R. commune were not known.
The classical experiments at Rothamsted Research in
Hertfordshire, UK, are field experiments studying the long-
term effects of different agricultural practices and other
factors affecting crop production and the environment.
Broadbalk is the world’s oldest continually running agricul-
tural experiment, growing winter wheat since 1843, and the
Hoosfield spring barley experiment started 9 years later.
Throughout the history of the experiment, plant and soil
samples have been retained in the Rothamsted Archive.
This enables the use of new analytical techniques on historical
samples, such as quantitative polymerase chain reaction
(qPCR) to quantify pathogen levels (Bearchell et al. 2005),
or pyrosequencing to quantify alleles within populations
(Gruber et al. 2002).
Rhynchosporium commune isolates were characterized for
sensitivity to four azoles, and a sensitivity shift was confirmed.
Two CYP51 genes were sequenced from R. commune and
shown to be paralogs CYP51A and CYP51B (sensu Mellado
et al. 2001), along with a pseudogene, CYP51A-p. The azole
sensitivity shift was not correlated with point mutations or
constitutive overexpression of either paralog, butCYP51A was
present only in less sensitive isolates. CYP51A was upregulated
in response to tebuconazole and complements yeast CYP51;
therefore, CYP51A, where present, encodes an additional
sterol 14-a demethylase with inducible overexpression.
Phylogenetic analysis of fungal CYP51s indicates that
CYP51A and CYP51B originate from a gene duplication
event basal to the filamentous ascomycetes, followed by mul-
tiple losses of CYP51A. Pyrosequencing analysis of samples
from the Hoosfield long-term spring barley experiment re-
vealed that CYP51A had declined in the R. commune popu-
lation by the start of the 20th century, but re-emerged in the
mid-1980s under selection by azoles.
Results
Ascomycete CYP51 Paralogs
CYP51 paralogs from fungal genomes on the Broad Institute
server, along with R. commune CYP51 genes and pseudogene,
are shown in supplementary figure S1, Supplementary
Material online, with gene names according to Nelson
(2009). The maximum-likelihood phylogenetic tree is summa-
rized in figure 1 and shown in full in supplementary figure S1,
Supplementary Material online. Basidiomycetes and hemias-
comycete yeasts each possess a single CYP51 paralog, apart
from an independent duplication in Coprinopsis cinerea.
CYP51 gene duplication took place around the origin of the
filamentous ascomycetes, forming clades CYP51A, CYP51B,
and CYP51C. All species studied have retained a CYP51B para-
log, but CYP51A has been lost from multiple lineages, and
CYP51C is found only in Fusarium spp. Further duplications of
CYP51A and CYP51B have taken place in some Aspergillus
species. The A. flavus “CYP51C” described by Liu et al.
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(2012) appears from this phylogeny to be a second CYP51A.
One R. commune CYP51 falls within the CYP51B clade, where
its closest relatives are Botrytis cinerea and Sclerotinia sclero-
tiorum CYP51B. The other R. commune CYP51 falls within the
CYP51A clade, where its closest relatives are sordariomycetes
including M. oryzae as the sequenced leotiomycetes lack
CYP51A. The R. commune CYP51 pseudogene is sister to
R. commune CYP51A, and is therefore referred to as
CYP51A-p.
Triazole Sensitivity in R. commune
Sensitivity of 57 R. commune isolates to the azole fungicides
propiconazole, tebuconazole, epoxiconazole, and prothioco-
nazole was measured by in vitro bioassay (supplementary
table S2, Supplementary Material online). Triazoles demon-
strate partial cross-resistance, so a principal component anal-
ysis (PCA) was carried out (fig. 2). 75.4% of variance was
encompassed by PC1, representing overall positive cross-
resistance against the four triazoles, with all loadings positive.
A further 17.2% of variance was encompassed by PC2, with
positive loadings for propiconazole and tebuconazole but a
negative loading for prothioconazole, showing incomplete
cross-resistance between prothioconazole and the other
azoles. The most sensitive group of isolates can be separated
from the others by PC1 alone, indicating an initial sensitivity
shift conferring positive cross-resistance against all four azoles
tested. A further shift from intermediate to less-sensitive iso-
lates, and further variation within the less-sensitive group,
involves variation in PC2 as well, so this shift shows only
partial cross-resistance, with prothioconazole affected differ-
ently from the other compounds.
Isolates from each sensitivity group were selected for mo-
lecular analysis. Sensitivity profiles for these isolates are shown
in figure 3. CYP51A and CYP51B were sequenced for these
isolates (GenBank accession numbers KF753641–KF753674).
No single nucleotide polymorphisms (SNPs) correlated with
azole sensitivity, but functional CYP51A sequences were ob-
tained from the intermediate and less-sensitive isolates,
whereas a pseudogene, with a frameshift indel and premature
stop codons, was sequenced from the sensitive isolates.
A polymerase chain reaction–restriction fragment length
polymorphism (PCR-RFLP) assay was developed to distin-
guish CYP51A from CYP51A-p. This revealed that sensitive
isolates possess CYP51A-p but not CYP51A, whereas interme-
diate and less sensitive isolates possess both CYP51A and
CYP51A-p (supplementary fig. S2, Supplementary Material
online). This difference in CYP51A copy number was con-
firmed by Southern blot (supplementary fig. S2,
Supplementary Material online). CYP51A-p was sequenced
from additional isolates (GenBank accession numbers
KF753666–KF753674) and all contained premature stop
codons.
Rhynchosporium commune CYP51A Expression
To test whether R. commune CYP51A still functions as a sterol
14a-demethylase, R. commune CYP51A and CYP51B were ex-
pressed in a Saccharomyces cerevisiae strain in which the
native CYP51 is under the control of a tetracycline-repressible
FIG. 1. Summary cladogram of maximum-likelihood phylogeny of
coding nucleotide sequences of fungal and outgroup CYP51 genes,
rooted with a CYP7 outgroup. The full phylogeny is shown in supple-
mentary figure S1, Supplementary Material online.
FIG. 2. Biplot of principal component 2 against principal component 1
from PCA of triazole log10[EC50] data for 61 Rhynchosporium commune
isolates. Percentage variation and loadings are listed in supplementary
table S3, Supplementary Material online. Black crosses indicate isolates
selected for sequence analysis. 1: RS 219; 2: K1124; 3: FI12-63; 4: R 9528.4;
5: R 9522.3; 6: QUB 30-10; 7: GKII 18-3-2; 8: GKII 18-2-3; 9: SAC 0003 1.4.8;
10: 788; 11: SAC 09/943/14; 12: QUB 12-3; 13: OSA 28-2-2; 14: RS 783.
Bold numbers indicate isolates with a functional CYP51A.
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promoter. Rhynchosporium commune CYP51A and CYP51B
were each able to complement S. cerevisiae CYP51 (fig. 4).
Yeast transformants were then tested for triazole sensitivity.
There was little difference in fungicide sensitivity, to triazoles
or to the non-DMI cycloheximide, between the CYP51A and
CYP51B transformants (fig. 4b).
Expression analysis of R. commune CYP51A and CYP51B
was carried out. No differences in constitutive expression of
either paralog were correlated with azole sensitivity. However,
following the addition of tebuconazole, CYP51B was only
upregulated around 5- to 10-fold if at all, whereas CYP51A,
where present, was upregulated around 100-fold. Therefore,
CYP51A expression is more inducible in response to the
effects of azoles than CYP51B (fig. 5).
Hoosfield Spring Barley Archive
Amplification of a 52-bp fragment of a reference gene
(R. commune -tubulin) was successful from samples from
33 different years, from 1892 to 2012. The CYP51A nested PCR
amplified products from R. secalis s.l. and not from R. orthos-
porum. All R. secalis s.l. DNA present in these samples was
confirmed as R. commune with 5% detection limit, except
2012, which was excluded from further testing.
A pyrosequencing assay was developed to distinguish
R. commune CYP51A from CYP51A-p (fig. 6). For most of
the 20th century, the majority of the R. commune population
at the Hoosfield experimental site lacked CYP51A, but in 1985,
levels of CYP51A rapidly increased, and subsequently the ma-
jority of the R. commune population possesses CYP51A. Logit-
transformed percentage data were analyzed with a Tukey
multiple-comparison test. Levels of functional CYP51A in
each year from 1985 onwards are significantly higher than
in each year from 1892 to 1983. No year up to 1983 has
significantly different levels of functional CYP51A from con-
trol isolates K1124 and FI12-63, which have only CYP51A-p,
whereas no year from 1985 onwards has significantly different
levels of CYP51A from isolates 788 and R9528.4, which have
both CYP51A and CYP51A-p (supplementary table S4,
Supplementary Material online). A further replicate DNA
extraction from the homogenized plant material gave similar
results (supplementary table S4, Supplementary Material
online).
CYP51A in Rhynchosporium Species
The genomes of three R. commune isolates, and one isolate
each of R. agropyri, R. secalis s.s., and R. orthosporum, sister
species to the R. secalis s.l. complex, have been sequenced.
The genomes were searched for CYP51 paralogs (GenBank
accession numbers KF753675–KF753687). All contain a
single CYP51B. Two R. commune isolates contain CYP51A-p
only, and one isolate contains CYP51A and CYP51A-p.
FIG. 4. (a) Growth of Saccharomyces cerevisiae strain YUG37::erg11 transformed with pYES3/CT (vector only) or pYES3-CT with Mycosphaerella
graminicola CYP51 (Mg51), Rhynchosporium commune CYP51A (Rc51A, two transformants) or R. commune CYP51B (Rc51B, two transformants) on
SD+GAL+ RAF agar, with and without 3mg ml1 doxycycline (DOX), with six inoculum concentrations of 1.25 106, 2.5 105, 5 104, 1 104,
2 103, and 4 102 cells ml1. DOX represses expression of the native S. cerevisiae CYP51 in strain YUG37::erg11. (b) Triazole and cycloheximide
log10[EC50] values of yeast transformants S. cerevisiae strain YUG37::erg11 transformed with R. commune CYP51A (black) or R. commune CYP51B (gray).
A: propiconazole, B: tebuconazole, C: epoxiconazole, D: prothioconazole, E: cycloheximide. Error bars indicate standard error of biological replicates.
FIG. 3. Azole log10[EC50] values of Rhynchosporium commune isolates
selected for target-site sequence analysis, and CYP51 amino acid sub-
stitutions. Black: propiconazole, gray: tebuconazole, dark gray: epoxico-
nazole, light gray: prothioconazole. Error bars indicate standard error
between biological replicates. 1: RS 219; 2: K1124; 3: FI12-63; 4: R 9528.4;
5: R 9522.3; 6: QUB 30-10; 7: GKII 18-3-2; 8: GKII 18-2-3; 9: SAC 0003 1.4.8;
10: 788; 11: SAC 09/943/14; 12: QUB 12-3; 13: OSA 28-2-2; 14: RS 783.
WT, wild type, identical to reference sequences from isolate 1130
(GenBank accession numbers KF753639 and KF753640); *no functional
CYP51A sequenced.
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Rhynchosporium agropyri and R. secalis s.s. contain a CYP51A
pseudogene, but with different stop codons from R. commune
CYP51A-p, whereas R. orthosporum contained only a func-
tional CYP51A. Therefore, a functional CYP51A was present in
the most recent common ancestor of R. orthosporum and R.
commune, followed by duplication of CYP51A and
pseudogenization of one copy in the R. commune lineage,
and loss of the functional copy from some isolates (fig. 7).
Discussion
A 10-fold shift in azole sensitivity in R. commune is correlated
with the presence of the CYP51A paralog. All isolates possess
CYP51B and a CYP51A-p pseudogene, but the functional
CYP51A is absent from azole sensitive isolates and present
in less-sensitive isolates. Further selection for reduced azole
sensitivity among isolates with CYP51A has resulted in a fur-
ther 10-fold difference in sensitivity to some azoles, which is
not correlated with mutations or overexpression of either
CYP51 paralog, implying that an additional, nontarget-site
mechanism is responsible for this second shift.
Analysis of R. commune populations in barley samples
from Hertfordshire, UK, shows an increase in CYP51A fre-
quency in the population from 1985, with CYP51A present
in the majority of the population thereafter. Similarly, the
oldest studied isolates lack CYP51A, whereas most modern
UK isolates have CYP51A. This correlates with a shift in tria-
zole sensitivity reported in UK field populations between
baseline monitoring from 1975 to 1981 and further surveys
from 1985 onwards (Kendall et al. 1993). This demonstrates
the value of the Rothamsted Classical Experiment archives to
analyze past evolutionary changes involving mutations which
have only now been identified.
FIG. 5. Expression of (a) CYP51A and (b) CYP51B in Rhynchosporium commune, relative to isolate R 9528.4 constitutive expression, with -tubulin as
endogenous control. Light gray: constitutive expression, without fungicide; dark gray: induced expression, following the addition of 1mg ml1
tebuconazole. Error bars indicate standard error of biological replicates. *CYP51A not present in these isolates: A low level of amplicon results from
nonspecific amplification of CYP51A-p.
FIG. 7. Maximum-likelihood phylogeny of coding nucleotide sequences
of CYP51 paralogs sequenced from Rhynchosporium species, with
Magnaporthe oryzae CYP51A, Botrytis cinerea CYP51B, and Fusarium
graminearum CYP51C. Rooted with Candida albicans CYP51 outgroup.
Node labels indicate bootstrap support.
FIG. 6. Percentage of functional CYP51A in Rhynchosporium commune
isolates, and populations sampled from the Hoosfield experiment at
Rothamsted Research, UK. Isolate 1: K1124; 2: FI12-63; 3: 788; 4: R
9528.4. Isolates K1124 and FI12-63 contain CYP51A-p only; isolates
788 and R 9528.4 contain both CYP51A-p and functional CYP51A.
Error bars indicate standard error of five technical replicates.
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The mechanism by which CYP51A reduces azole sensitivity
appears to be inducible target-site overexpression.
Rhynchosporium commune CYP51A is able to complement
S. cerevisiae CYP51, so it is a functional sterol 14a-
demethylase, and in R. commune, CYP51A is upregulated
following exposure to an azole, so CYP51A may be able to
maintain CYP51 function when CYP51B is inhibited by azoles.
Previously reported cases of reduced azole sensitivity due to
target-site overexpression have all involved constitutive
overexpression of an existing paralog due to promoter inserts
or gene duplication. Acquired reductions in azole sensitivity
due to CYP51 duplication have been reported due to chro-
mosome duplication in C. glabrata (Marichal et al. 1997);
isochromosome formation, with duplication of chromosome
arm 5L containing CYP51, two efflux pump encoding genes
and one ABC transporter transcription factor, in C. albicans
(Selmecki et al. 2006); and disomy of chromosome 1, contain-
ing CYP51 and ABC transporter encoding gene AFR1, in
Cryptococcus neoformans (Sionov et al. 2010). However, in
all of these cases, this involved duplication of an existing
gene, producing a second identical copy rather than a func-
tionally divergent paralog. CYP51A demonstrates functional
divergence from CYP51B through different patterns of tran-
scriptional regulation, including greater upregulation in re-
sponse to azoles. Neofunctionalization of fungal genes often
involves changes in transcriptional regulation rather than
changes in substrate (Skamnioti et al. 2008), and often altered
expression evolves primarily in one copy whereas the other
retains the original pattern (Gu et al. 2005). Intrinsic sequence
differences between CYP51A and CYP51B contribute to re-
duced intrinsic azole sensitivity in A. fumigatus (Martel et al.
2010) and F. graminearum (Fan et al. 2013), but R. commune
CYP51A conferred similar azole sensitivity to CYP51B when
expressed in yeast, suggesting that upregulation of CYP51A,
rather than reduced azole binding due to intrinsic sequence
differences, is the main mechanism of reduced azole sensitiv-
ity in R. commune isolates possessing CYP51A.
Although CYP51 paralogs have been extensively studied in
a few species, such as A. fumigatus where CYP51A mutations
confer azole resistance, in others species, knowledge of CYP51
paralog presence is based only on a single isolate selected for
genome sequencing. Therefore, genome resequencing of mul-
tiple isolates may reveal paralog presence polymorphisms in
other species, and possible multiple CYP51 paralogs should be
considered in future when investigating azole sensitivity shifts.
Further investigation is also needed concerning the reasons
for the emergence of CYP51A, and its retention in some
fungal lineages, in the absence of selection by azoles.
CYP51A expression is induced in CYP51B deletion mutants
(Fan et al. 2013), as well as following CYP51 inhibition by
azoles, suggesting that CYP51A is upregulated in response
to disruption of ergosterol biosynthesis. Therefore, presence
of this inducible CYP51, in addition to the constitutively ex-
pressed CYP51B found in all filamentous ascomycetes, would
allow a fungus to respond to fluctuating ergosterol require-
ments, but it is not yet clear which aspects of fungal biology
and lifestyle make this necessary in some species and not
others.
Phylogenetic analysis places R. commune CYP51A in a
monophyletic clade with other filamentous ascomycete
CYP51As, which diverged from CYP51B around the origin of
the filamentous ascomycetes, 320–520 Ma (Lu¨cking et al.
2009). This indicates a single origin of CYP51A followed by
multiple losses, rather than an independent recent origin in
R. commune. However, the origin of CYP51A-p, and partial
loss of CYP51A, in the R. commune lineage took place far more
recently. Rhynchosporium orthosporum possesses a functional
CYP51A and not a pseudogene, whereas the sequenced iso-
lates of R. agropyri and R. secalis s.s. possess only a pseudo-
gene. The R. orthosporum CYP51A forms a sister group to
R. commune CYP51A and CYP51A-p. Therefore, CYP51A du-
plication took place in the R. commune lineage after it
diverged from R. orthosporum, 14.5–35 ka BP (Zaffarano
et al. 2008), but before the divergence of R. agropyri, R. secalis
s.s., and R. commune from their most recent common ances-
tor, 1.3–3.6 ka BP (Zaffarano et al. 2008). This was followed in
the R. commune lineage by pseudogenization of one copy,
and loss of the functional copy in some of the population.
Further study of R. agropyri and R. secalis s.s. would be needed
to ascertain whether CYP51A pseudogenization occurred
independently in these lineages or once in the R. secalis s.l.
common ancestor, and whether any isolates of these species
possess a functional CYP51A. The gene phylogeny confirms
that CYP51A was retained within the R. commune lineage,
and not regained by horizontal gene transfer, in contrast to
the acquisition of antibiotic resistance genes in clinical bac-
teria by horizontal gene transfer from soil bacteria previously
exposed to naturally occurring microbial antibiotics (Forsberg
et al. 2012).
Having declined in the R. commune population, CYP51A
later re-emerged under selection by azoles in the late 20th
century. Most research into the origin and fate of duplicate
genes considers possible outcomes in terms of loss or fixation
in a species, and it has been demonstrated that most intra-
specific gene copy number variations result from very recent
duplication events, as older duplicates have already been lost
or fixed, and most established, diverged duplicates are main-
tained by purifying selection (Schrider and Hahn 2010).
Comparative genomics has revealed cases of fixed paralog
losses following a change in selection in some taxa, such as
repeated gene losses from the olfactory receptor gene family
in microsmic mammals (Rouquier et al. 2000), or extensive
gene losses in obligate parasites (Spanu et al. 2010). However,
the Rothamsted archive samples, covering a time frame in-
cluding a known change in selection, provide the temporal
resolution to detect changes in paralog frequency over time,
enabling us to detect the previous near-loss of a paralog fol-
lowed by its re-emergence due to a further change in selection.
Furthermore, as phylogenetic analyses have shown that
the functional CYP51A in R. commune originated long
before azole use, its re-emergence provides an example of
an adaptation to a new environment that has been selected
from standing genetic variation rather than arising from a de
novo mutation (Barrett and Schluter 2008), whereas previous
studies of other fungicide resistance alleles have pointed to de
novo mutational origins (Torriani et al. 2009; Camps et al.
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2012). Although ancient origins have previously been dem-
onstrated for resistance genes to antibiotics based on natural
microbial products (D’Costa et al. 2011), the triazoles are
synthetic in origin with no know natural analogs and there-
fore their use imposes a previously unencountered selective
pressure. Standing variation may allow resistance to evolve
more quickly, or may result in increased probability of fixation
where the fitness benefit is smaller and a de novo mutation
may have been lost through genetic drift (Hermisson and
Pennings 2005). Furthermore, as this standing variation com-
prises a trait that has been lost from multiple ascomycete
lineages, the availability of CYP51A re-emergence as an adap-
tive pathway is historically contingent upon CYP51A still
having been present at low levels in the population at the
point when selection pressures altered due to anthropogenic
fungicide use.
Materials and Methods
Bioinformatic and Phylogenetic Analysis
CYP51 sequences were obtained from fungal genomes on
the Broad Institute server (http://www.broadinstitute.org/sci
ence/data, last accessed April 16, 2014), along with
Mycobacterium tuberculosis, Trypanosoma cruzi, Homo sapi-
ens, Arabidopsis thaliana CYP51G1, and Mus musculus CYP51,
with Mus musculus CYP7A1 as an outgroup (Aoyama et al.
1996). A text search was carried out for annotated CYP51
genes, followed by BLAST searches against each genome
with S. cerevisiae CYP51, and with CYP51A and CYP51C
from the nearest available relative for species where these
paralogs were not found. Start sites, introns, and stop sites
were checked manually, and introns removed as they were
too variable to align unambiguously. Predicted amino acid
sequences were aligned using M-Coffee (Notredame et al.
2000), and the corresponding coding nucleotide alignment
generated using PAL2NAL (Suyama et al. 2006). Model selec-
tion was carried out in jModelTest 0.1.1 (Posada 2008), se-
lecting by AICc. Maximum-likelihood phylogenetic analysis
was carried out in PhyML (Guindon and Gascuel 2003), im-
plemented through the TOPALi v2.5 platform (Milne et al.
2009), using a TVM+ I+G model, with 100 bootstrap runs.
Fungicide Sensitivity Testing
Isolates used are listed in supplementary table S1,
Supplementary Material online. Isolates had been stored as
spore suspensions on silica gel at80 C. Isolates were grown
on Czapek dox agar with 0.5% mycological peptone, with an
inoculum density of 1.25 105 spores per 90 mm Petri dish,
at 18 C for 10 days. Sensitivity testing was carried out as
described by Pijls et al. (1994), using Sabouraud medium,
R. commune spores at 1.25 105 spores ml1, and the fol-
lowing technical-grade fungicides: epoxiconazole, 50mg ml1
with 2.5-fold dilutions; prothioconazole, propiconazole, tebu-
conazole, 100mg ml1 with 3-fold dilutions, repeated with
300mg ml1 for less sensitive isolates. Plates were incubated
at 18 C for 7 days, then fungal growth was measured by
optical absorbance at 620 nm using an Optima Fluostar
plate reader (BMG Labtech, Germany), in well-scanning
mode with a 4 4 matrix of scanning points within a
3-mm diameter. The accompanying software was used to
fit a dose–response curve (4-parameter fit) and calculate
EC50 values. Cross-resistance was assessed by PCA using the
correlation matrix of log10 transformed EC50s for the four
fungicides, in GenStat 14th Edition (VSN International,
Hertfordshire, UK).
CYP51 Sequencing
Initial fragments were amplified using degenerate primers
CYP51 3F and CYP51A CIGEK rv for CYP51A, and DMIRES F1
and 14DM R2 for CYP51B (supplementary table S3,
Supplementary Material online). The remainder of each
gene (GenBank accession numbers KF753639–KF753640)
was found by genome-walking using the GenomeWalker
Universal Kit (Clontech, CA). Libraries were prepared from
isolate 1130 (Rohel et al. 1998) genomic DNA, with restric-
tion enzymes DraI, PvuII, EcoRV, and StuII. Three reactions in
the 50-direction and one in the 30-direction were needed to
obtain the complete coding sequence of CYP51A, and two
reactions in the 50-direction and one in the 30-direction for
CYP51B. Genome-specific primers (GSP1 and GSP2) used in
successive reactions are listed in supplementary table S3,
Supplementary Material online. PCR products were purified
using the Wizard SV Gel and PCR Clean-Up System, ligated
into pGEM-T Easy plasmid vector using T4 DNA ligase and
cloned in JM109 competent cells (all Promega). Plasmid
DNA was extracted and purified using the GeneElute
(Sigma) or QIASpin (Qiagen) mini-prep kits, then sequenced
by Eurofins MWG (Germany) using sequencing primers
M13uni and M13rev (Messing 1983) and the sequences as-
sembled in Vector NTI 10 (Invitrogen, CA).
CYP51B, CYP51A, and CYP51A-p were sequenced from iso-
lates with a range of triazole sensitivities (fig. 2): K1124, FI12-
63, RS-219, QUB 30-10, R 9528.4, 9522.3, 788, SAC 1-4-8
(0003), GKII 18-2-3, GKII 18-3-2, SAC 09/943/14, QUB 12-3,
OSA 28-2-2, and RS 783. Isolates were grown in Sabouraud
liquid medium for 10 days. Fungal material was harvested by
filtration and freeze-dried. DNA was extracted as in Motteram
et al. (2009).
CYP51A and CYP51B were amplified using PCR, carried out
with Phusion High-Fidelity DNA Polymerase (Finnzymes Oy,
Espoo, Finland), withCYP51B and CYP51A primers Forwards 1
and Reverse 1 (supplementary table S3, Supplementary
Material online). Products were purified and sequenced by
Eurofins MWG (Germany), with the nested and internal pri-
mers listed in supplementary table S3, Supplementary
Material online. CYP51A-p was amplified using Easy-A High-
Fidelity PCR Cloning Enzyme (Stratagene) with primers listed
in supplementary table S3, Supplementary Material online.
Products were cloned and sequenced as described for
genome walking, with additional sequencing reactions using
internal primers (supplementary table S3, Supplementary
Material online).
PCR–RFLP Assay
Two PCR reactions were carried out per isolate, one to am-
plify CYP51A and one to amplify CYP51A-p, using Phusion
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High-Fidelity DNA Polymerase (Finnzymes Oy) with primers
listed in supplementary table S3, Supplementary Material
online. Restriction digests were carried out with enzymes
PstI and HindIII (Promega), with 3-h incubation time.
CYP51A copy number was confirmed by Southern blot as
described by Motteram et al. (2009). Ten micrograms of
genomic DNA from isolates 788, K1124, and FI12-63 was
digested with high concentration PstI and EcoRV (Promega).
The probe was amplified from pGEM-T Easy plasmids con-
taining CYP51A from isolate 788 cDNA, using primers
Southern F and Reverse 10D (supplementary table S3,
Supplementary Material online) to amplify a 734-bp fragment
of exon 3.
Yeast Complementation
Rhynchosporium commune CYP51A and CYP51B were ampli-
fied from a 1/10 dilution of isolate 788 cDNA using Easy-A
High-Fidelity PCR Cloning Enzyme (Stratagene), with primers
CYP51A pYES F2 and pYES R and CYP51B pYES F and pYES R
(supplementary table S3, Supplementary Material online).
PCR product was purified using the Wizard SV Gel and
PCR Clean-Up System (Promega), and a sample of the
CYP51A product digested with PstI and HindIII to confirm it
was CYP51A and not CYP51A-p. KpnI and a SacI restriction
sites were incorporated by the forward and reverse primers,
respectively. An internal KpnI site was removed from CYP51B
using the QuikChange II Site-Directed Mutagenesis Kit
(Agilent Technologies, CA, USA) with primer pYES mut (sup-
plementary table S3, Supplementary Material online). Cloning
in yeast expression vector pYES2/CT (Invitrogen), transforma-
tion into S. cerevisiae YUG37:erg11 strain, and complementa-
tion analysis were carried out as described by Cools et al.
(2010), with pYES-Mg51wt as a positive control. Fungicide
sensitivity testing was carried out as in Cools et al. (2010),
but with maximum fungicide concentrations of
0.005mg ml1 for epoxiconazole and propiconazole,
0.05mg ml1 for prothioconazole and tebuconazole and
5mg ml1 for cycloheximide, all with 2-fold serial dilutions.
CYP51 Expression
Rhynchosporium commune isolates QUB 30-10, 788, K1124,
QUB 12-3, FI12-63, R 9528.4, GKII 18-2-3, and RS 783 783 were
grown liquid culture, in 100-ml Sabouraud liquid medium at
2.5 104 spores ml1 at 20 C, 150 rpm, with two biological
replicates of treatment and control culture for each isolate.
After 7 days, tebuconazole solution in acetone to a final con-
centration of 1mg ml1 was added. An equal volume of ace-
tone without tebuconazole was added to the control cultures.
After 10 days, cultures were harvested by vacuum-filtration,
then freeze-dried. RNA extraction was carried out with TRIzol
Reagent (Invitrogen), according to manufacturer’s instruc-
tions, followed by overnight precipitation with 4 M lithium
chloride and treatment with the TURBO DNA-free Kit
(Applied Biosystems, CA). cDNA was synthesized with the
Superscript III first-strand synthesis system (Invitrogen).
End-point PCR reactions were carried out using Red Hot
Taq (ABgene, Epsom, UK) with intron-spanning primer pair
CYP51B Expression F and CYP51B Expression R (supplemen-
tary table S3, Supplementary Material online) to check for
genomic DNA contamination.
Quantitative PCR was carried out using SYBR Green
JumpStart Taq ReadyMix (Sigma), with CYP51B, CYP51A,
and -tubulin primers Expression F and Expression R (supple-
mentary table S3, Supplementary Material online). Relative
quantification was calculated by the 2CT method (Livak
and Schmittgen 2001), with -tubulin as endogenous control
and isolate R9528.4 without fungicide as calibrator sample.
Hoosfield Long-Term Experiment and
Pyrosequencing Assay
Spring barley has been grown on the Hoosfield plot at
Rothamsted Research, in Harpenden, UK, every year since
1852, apart from 1912, 1933, 1943, and 1967 when it was
left fallow to control weeds. Dried leaf, grain, and soil samples
have been retained each year. Straw samples used were from
Plot 4A, receiving 48 kg N ha1 in the form of ammonium
sulfate. From 1968, this plot was divided into four subplots
receiving different nitrogen doses in the form of calcium am-
monium nitrate, and samples used were from the subplot
receiving 48 kg N ha1.
One gram of material was taken from the archive sample,
ground using a sterilized pestle and mortar, then extraction
buffer was added and DNA extractions carried out as de-
scribed by Motteram et al. (2009), with two replicate extrac-
tions from each homogenized sample. Rhynchosporium
secalis s.l. DNA presence and quality were tested by end-
point PCR amplification of a 520-bp fragment of reference
gene -tubulin using primers Rs F3 and Rs R3 (supplementary
table S3, Supplementary Material online), and up to 3 years
per decade were selected for analysis. Rhynchosporium secalis
s.l. species present were identified based on a C/T SNP at
nucleotide 391 of -tubulin (Zaffarano et al. 2011), with a
nested PCR using primers RhyUF1 and RhyUR1 then
PyroRhF1Bio and PyroRHR1, followed by a pyrosequencing
assay using the PyroMark system (Qiagen) and the PSQ96
instrument (Biotage, Uppsala, Sweden), programmed to an-
alyze the sequence TC/TGCAGATCCAAGGTAGAACTTACA
CT, using the nucleotide dispensation order ATCTGCAGA,
with primer PyroRhS1 (supplementary table S3,
Supplementary Material online).
To distinguish CYP51A from CYP51A-p, a pyrosequencing
assay was developed to detect a 4-bp indel at nucleotide 418.
A nested PCR was carried out with primers Pyro F3 and Pyro
R2 then primers Del F1 and Del R1 (supplementary table S3,
Supplementary Material online) and the products pyrose-
quenced using the PyroMark system (Qiagen) and the
PSQ96 instrument (Biotage), to analyze the sequence
CA[TTTC]CTTCCAGCCCAAGATAAACAGTCAT, using the
nucleotide dispensation order GCATCGTCA, with primer
Del S1 (supplementary table S3, Supplementary Material
online).
Rhynchosporium Spp. Genome Analysis
The genomes of R. commune isolates UK7, AU2 (Lehnackers
and Knogge 1990), and 13-13 (A. Avrova, The James Hutton
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Institute); R. secalis s.s. isolate 02CH4-6a.1 (Zaffarano et al.
2008); R. agropyri isolate 04CH Rac A.6.1; and R. orthosporum
isolate 02CH4 Ba¨r A.1.1.3 (B. McDonald, ETH Zurich) have
been sequenced and are currently prepared for publication.
A BLAST search was carried out against R. commune CYP51A,
CYP51A-p, and CYP51B. Introns were predicted and coding
sequences translated. Each CYP51 was cloned and rese-
quenced by Sanger sequencing, as described for CYP51A-p
sequencing with primers listed in supplementary table S3,
Supplementary Material online, to confirm the genome as-
sembly. Predicted amino acid sequences, along with B. cinerea
CYP51B and M. oryzae CYP51A (the closest relatives of
R. commune in supplementary fig. S1, Supplementary
Material online), F. graminearum CYP51C, and C. albicans
CYP51 as an outgroup were aligned with M-Coffee, and
coding nucleotides were aligned with PAL2NAL.
Substitution models were predicted with jModeltest, and
phylogenetic reconstruction carried out in PhyML with the
GTR+G model and 100 bootstrap runs.
Supplementary Material
Supplementary tables S1–S4 and figures S1 and S2 are avail-
able at Molecular Biology and Evolution online (http://www.
mbe.oxfordjournals.org/).
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